Welcome, Guest. Please login or register.
July 15, 2024, 01:28:50 pm

Login with username, password and session length

  • Total Posts: 55130
  • Total Topics: 4851
  • Online Today: 209
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 am)
Users Online
Users: 0
Guests: 41
Total: 41


Welcome to the Hep Forums, a round-the-clock discussion area for people who have Fatty Liver Disease, Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Fatty Liver Disease Tied to Risk of Metabolic Problems in People With HIV  (Read 9094 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 784
    • Hep Mag
Among people with HIV, non-alcoholic fatty liver disease (NAFLD) is associated with a higher risk of metabolic health problems, Healio reports.

Fatty liver disease is the most common liver disease in the global general population and is associated with type 2 diabetes, irregular blood lipids and high blood pressure. The condition can give rise to inflammation, which over time can lead to fibrosis, cirrhosis and liver cancer. In its more severe form, fatty liver disease is known as non-alcoholic steatohepatitis (NASH).

As described in The Journal of Infectious Diseases, a research team led by Thomas Krahn, MD, of McGill University Health Centre in Montreal, assessed the association between fatty liver disease and new diagnoses of metabolic health conditions among 485 people with HIV who did not have hepatitis B or C viruses (HBV or HCV). They drew their sample from the LIVEr in HIV, or LIVEHIV, cohort.

For more...


© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.